kinase inhibitors - Robuta Search

https://www.bioxorio.com/ multidrug resistance by tyrosine kinase inhibitors in cell biology tyrosine kinase inhibitors resistance cell biology https://www.ebi.ac.uk/chembl/explore/document/CHEMBL1150976 Document: The selectivity of protein kinase inhibitors: a further update. (CHEMBL1150976) - ChEMBL Report card for Document The selectivity of protein kinase inhibitors: a further update. (CHEMBL1150976). Biochem J, The specificities of 65 compounds reported... protein kinase inhibitors https://pmc.ncbi.nlm.nih.gov/articles/PMC11421408/ Real-World Experience With Janus Kinase Inhibitors in Immune-Mediated Diseases: Clinical Experience... Background: Several Janus kinase (JAK) inhibitors have been developed in recent years. These agents are widely applicable in clinical practice as an... real world experience immune mediated diseases janus kinase https://portefeuillessac.com/ Rho Kinase Inhibitors for intervertebral disc disease – Rho Kinase Inhibitor intervertebral disc disease kinase inhibitors rho https://www.transparencymarketresearch.com/anaplastic-lymphoma-kinase-inhibitors-market.html Anaplastic Lymphoma Kinase Inhibitors Market Insights 2027 Anaplastic Lymphoma Kinase Inhibitors Market is driven by increase in number of strategic collaborations between manufacturers and research institutes along... kinase inhibitors market insights lymphoma https://www.ncbi.nlm.nih.gov/books/NBK563322/?report=printable Tyrosine Kinase Inhibitors - StatPearls - NCBI Bookshelf Tyrosine kinase inhibitors (TKI) are a group of pharmacologic agents that disrupt the signal transduction pathways of protein kinases by several modes of... tyrosine kinase inhibitors statpearls ncbi bookshelf https://www.epo.org/fr/boards-of-appeal/decisions/t050223eu1 T 0223/05 (Tyrosine kinase inhibitors/WARNER-LAMBERT) du 24.04.2007 tyrosine kinase inhibitors https://www.transparencymarketresearch.com/non-receptor-tyrosine-kinase-inhibitors-market.html Non-receptor Tyrosine Kinase Inhibitors Market Insight 2025 Non-receptor Tyrosine Kinase Inhibitors Market is driven by robust health care infrastructure, favorable reimbursement policies, presence of key players, high... tyrosine kinase inhibitors market insight non receptor https://www.goodrx.com/classes/kinase-inhibitors/tyrosine-kinase-inhibitors What Are Tyrosine Kinase Inhibitors? Uses, Types, and More - GoodRx Tyrosine kinase inhibitors (TKIs) are drugs used to treat certain types of cancer. Learn more about tyrosine kinase inhibitors with this guide from GoodRx. tyrosine kinase inhibitors what are and more uses types https://www.researchandmarkets.com/reports/5950407/tyrosine-kinase-inhibitors-market-global Tyrosine Kinase Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,... The Global Tyrosine Kinase Inhibitors Market, valued at USD 48.16B in 2024, is projected to reach USD 76.14B by 2029, growing at a 8.1% CAGR. tyrosine kinase inhibitors global industry https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2017.01514/full Frontiers | Plant Cyclin-Dependent Kinase Inhibitors of the KRP Family: Potent Inhibitors of... Root-knot nematodes (RKN), Meloidogyne spp., are distributed worldwide and impose severe economic damage to many agronomically important crops. The plant cel... kinase inhibitors of the frontiers plant dependent https://www.cochrane.org/zh-hans/evidence/CD012381_oral-janus-kinase-inhibitors-tofacitinib-maintenance-remission-ulcerative-colitis Oral Janus kinase inhibitors (tofacitinib) for maintenance of remission in ulcerative colitis |... janus kinase for maintenance https://www.acc.org/Latest-in-Cardiology/Articles/2021/06/04/12/17/Protein-Kinase-Inhibitors-Associated-With-Pro-Arrhythmia Protein Kinase Inhibitors Associated With Pro-Arrhythmia - American College of Cardiology protein kinase inhibitors associated with american college https://www.mdpi.com/1420-3049/30/10/2183 Pharmacophore Modeling of Janus Kinase Inhibitors: Tools for Drug Discovery and Exposition... Pesticides are essential in agriculture for protecting crops and boosting productivity, but their widespread use may pose significant health risks. Farmworkers... tools for drug discovery janus kinase https://pmc.ncbi.nlm.nih.gov/articles/PMC5641865/ A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific... Bacterial signaling systems such as protein kinases and quorum sensing have become increasingly attractive targets for the development of novel antimicrobial... screen for kinase inhibitors https://www.pharmaceutical-technology.com/comment/janus-kinase-inhibitors/ Atopic dermatitis: survey reveals physician attitudes on Janus kinase inhibitors - Pharmaceutical... Mar 16, 2023 - The late-stage atopic dermatitis (AD) pipeline is full of promising candidates, including the Janus kinase (JAK) inhibitor class. atopic dermatitis janus kinase survey reveals physician https://www.transparencymarketresearch.com/braf-kinase-inhibitors-market.html BRAF Kinase Inhibitors Market Trends and Forecast to 2027 High prevalence of non-small-cell lung carcinoma (NSCLC) is likely to be key contributing factor for the growth of BRAF Kinase Inhibitors Market, Large number... trends and forecast kinase inhibitors braf market https://www.jci.org/assets/326521/powerpoint JCI - Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum... kinase inhibitors https://www.mdpi.com/2077-0383/12/14/4827 Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with... Objectives: To determine whether drug-induced lymphocytopenia is associated with drug retention rates of JAKi (tofacitinib or baricitinib) in rheumatoid... retention rates janus kinase https://www.kinarx.com/ KinaRx – A biotech company developing novel kinase inhibitors for cancer. KinaRx Changing the drug discovery paradigm to anticipate cancer patients’ needs with novel classes of kinase inhibitors. Learn More News Company Overview... biotech company kinase inhibitors https://www.spandidos-publications.com/10.3892/mco.2015.572 Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in... International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis. tyrosine kinase inhibitors growth factor vascular endothelial receptor https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.674748/full Frontiers | Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A... Background: Off-target effects in chronic myeloid leukemia (CML) patients treated with Tyrosine kinase inhibitors (TKI) are associated with cardiovascular t... tyrosine kinase inhibitors chronic myeloid leukemia arterial hypertension https://www.goodrx.com/classes/fgfr-kinase-inhibitors Popular Fgfr Kinase Inhibitors List, Drug Prices and Medication Information - GoodRx Compare the cost of prescription and generic Fgfr Kinase Inhibitors medications. See information about popular Fgfr Kinase Inhibitors, including the conditions... kinase inhibitors drug prices medication information popular fgfr https://www.michaeljfox.org/grant/insights-lrrk2-kinase-inhibitors Insights into LRRK2 Kinase Inhibitors | Parkinson's Disease Study Rationale: Mutations in LRRK2 cause an inherited form of Parkinson's disease (PD), and variations in LRRK2 can increase disease risk, indicating that the... kinase inhibitors insights parkinson disease https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2017.00113/full Frontiers | Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor... Sensitizing mutations in the epidermal growth factor receptor (EGFR) predict response to EGFR tyrosine kinase inhibitors (TKIs) and both first and second gen... tyrosine kinase inhibitors epidermal growth factor third generation frontiers https://www.biospace.com/kinase-inhibitors-market-oral-jak-inhibitors-hold-promising-potential-for-treatment-of-alopecia-areata Kinase Inhibitors Market: Oral JAK Inhibitors Hold Promising Potential for Treatment of Alopecia... Nov 25, 2020 - According to the report, the global kinase inhibitors market was valued at ~US$ 46.4 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. kinase inhibitors https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.790125/full Frontiers | Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review Vitiligo is a multifactorial reversible skin disorder characterized by distinct white patches that result from melanocyte destruction. Activated CXCR3+ CD8+ ... janus kinase the treatment frontiers inhibitors https://pmc.ncbi.nlm.nih.gov/articles/PMC11588072/ Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor... Transcriptomic plasticity of TNBC promotes metastatic growth and renders these cancers resistant to targeted therapies. Inhibition of CDK8/19 Mediator kinases,... triple negative breast cancer kinase inhibitors https://www.news-medical.net/whitepaper/20250428/Insights-into-kinase-inhibitors-therapeutic-potential-in-neurodegenerative-diseases.aspx Kinase inhibitors in neurodegenerative disease Aug 4, 2025 - Explore how kinase inhibitors are transforming neurodegenerative disease research through targeted therapy. kinase inhibitors neurodegenerative disease https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1188062/full Frontiers | Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of... Due to an error in the editorial process, an incorrect version of the article was published. Significant textual revisions to the published article are detai... drug resistance kinase inhibitors frontiers erratum mechanism https://www.jci.org/articles/view/89857 JCI - Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum... kinase inhibitors https://www.mdpi.com/2077-0383/13/3/766 Predictors of Efficacy of Janus Kinase Inhibitors in Patients Affected by Ulcerative Colitis Personalised medicine and the identification of predictors of the efficacy of specific drugs represent the ultimate goal for the treatment of ulcerative... janus kinase https://www.mdpi.com/1420-3049/28/2/689 Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase One crucial strategy for the treatment of breast cancer involves focusing on the Vascular Endothelial Growth Factor Receptor (VEGFR-2) signaling system.... https://www.ganjingworld.com/article/1ib7k6c3cgi3Jh9PnbnC9P3Vt18u1c/brutons-tyrosine-kinase-btk-inhibitors-market-2025-2035-demand-key-players-and-key-regions-analysis Bruton's Tyrosine Kinase (BTK) Inhibitors Market 2025-2035 Demand, Key Players and Key Regions... https://www.prnewswire.com/news-releases/nuvalent-announces-new-preclinical-data-for-selective-kinase-inhibitors-nvl-330-and-nvl-655-301659259.html Nuvalent Announces New Preclinical Data for Selective Kinase Inhibitors NVL-330 and NVL-655 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.780798/full Frontiers | Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced... The oral tyrosine kinase inhibitors (TKI) sorafenib, regorafenib, and cabozantinib are approved for advanced hepatocellular carcinoma (aHCC) and improve surv... https://elifesciences.org/articles/88224 Water and chloride as allosteric inhibitors in WNK kinase osmosensing | eLife WNKs sense osmotic pressure by binding specific water molecules to the inactive dimeric configuration of WNK1 and WNK3, integrating signals with chloride... water chloride https://www.rcsb.org/structure/4JBO RCSB PDB - 4JBO: Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of... Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules https://www.wikidata.org/wiki/Q40465454 Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large... scientific article published on January 2005 https://www.jci.org/articles/view/34588/figure/1 JCI - Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of... https://pmc.ncbi.nlm.nih.gov/articles/PMC11052498/ QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived... Cancer is a serious threat to human life and social development and the use of scientific methods for cancer prevention and control is necessary. In this... molecular docking dynamic simulation https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.1064472/full Frontiers | Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update Protein Kinase is enzymes that transfer phosphate to protein and result in the modification of the protein. The human genome encodes around 538 kinase. Kinas... https://www.cochrane.org/de/evidence/CD015140_do-epidermal-growth-factor-receptor-egfr-tyrosine-kinase-inhibitors-tkis-after-lung-cancer-surgery Do epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) after lung cancer... epidermal growth factor tyrosine kinase inhibitors https://www.rcsb.org/structure/3NRM RCSB PDB - 3NRM: Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitors Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitors rcsb pdb https://www.ncbi.nlm.nih.gov/Structure/pdb/3JY9 3JY9: Janus Kinase 2 Inhibitors Tyrosine-protein kinase JAK2(3S)-3-(4-hydroxyphenyl)-1,5-dihydro-1,5,12-triazabenzo[4,5]cycloocta[1,2,3-cd]inden-4(3H)-oneSODIUM ION janus kinase inhibitors https://www.rcsb.org/structure/2GMX RCSB PDB - 2GMX: Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular... Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity https://www.cochrane.org/evidence/CD015140_do-epidermal-growth-factor-receptor-egfr-tyrosine-kinase-inhibitors-tkis-after-lung-cancer-surgery Do epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) after lung cancer... epidermal growth factor tyrosine kinase inhibitors https://pmc.ncbi.nlm.nih.gov/articles/PMC11291109/ SGLT2 inhibitors activate pantothenate kinase in the human heart - PMC Inhibitors of sodium glucose cotransporter-2 (SGLT2i) demonstrate strong symptomatic and mortality benefits in the treatment of heart failure but appear to do... the human heart inhibitors activate kinase pmc https://www.rcsb.org/structure/1WBW RCSB PDB - 1WBW: Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead... Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation. https://www.transparencymarketresearch.com/small-molecule-kinase-inhibitors-market.html Small Molecule Kinase Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends and... [Original Price: $4795] [Discount Price: $4315.5] You Will Get Custom Report at Syndicated Price on Small Molecule Kinase Inhibitors Market - Global Industry... https://www.prnewswire.com/news-releases/discoverx-and-the-sgc-partner-to-make-an-annotated-collection-of-600-kinase-inhibitors-freely-available-300227298.html DiscoverX and the SGC Partner to Make an Annotated Collection of 600 Kinase Inhibitors Freely... /PRNewswire/ -- DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, today announced... https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1462254/full Frontiers | Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in... BackgroundVEXAS syndrome, a recently identified systemic autoinflammatory disorder, poses new diagnostic and management challenges. Based on experience with ... efficacy and safety https://www.jci.org/articles/view/76094 JCI - Targeting cancer with kinase inhibitors jci targeting cancer kinase inhibitors https://www.biospace.com/b-discoverx-b-and-the-b-sgc-b-partner-to-make-an-annotated-collection-of-600-kinase-inhibitors-freely-available DiscoverX And The SGC Partner To Make An Annotated Collection Of 600 Kinase Inhibitors Freely... https://www.preprints.org/manuscript/202307.2046 An Updated Review of Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design... Small molecule kinase inhibitors (SMKIs) are one of the heightened concerns in the field of drug research and development. There are seventy-nine (up to July... https://www.rcsb.org/structure/4C61 RCSB PDB - 4C61: Inhibitors of Jak2 Kinase domain Inhibitors of Jak2 Kinase domain rcsb pdb inhibitors kinase domain https://www.hu-berlin.de/en/forschungsinformationssystem/projekt-details/charakterisierung-der-wechselwirkung-niedermolekularer-kinase-inhibitoren-mit-membranen-zum-verstaendnis-ihrer-spezifischen-zellulaeren-effekte Characterizing the Interaction of Small-Molecule Kinase Inhibitors With Membranes To Understand... small molecule https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1342810/full Frontiers | Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses Background: Clinicians and healthcare policy makers were drenched with a deluge of overlapping meta-analyses (MAs), and the necessity for comprehensive and c... https://pmc.ncbi.nlm.nih.gov/articles/PMC8462848/ Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent... A series of quinazolin-4(3H)-one derivatives were synthesised and evaluated for their cytotoxicity against human Caucasian breast adenocarcinoma (MCF-7) and... tyrosine kinase inhibitors https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.950035/full Frontiers | Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD Introduction: Chronic inflammation is the core mechanism of the development of COPD. Corticosteroid resistance in COPD limited its anti-inflammatory potency.... https://dermnetnz.org/topics/egfr-and-protein-kinase-inhibitors Cutaneous side effects of EGFR and protein kinase inhibitors May 23, 2024 - Cutaneous side effects of EGFR and protein kinase inhibitors, Epidermal growth factor receptor inhibitors adverse effects on the skin. Authoritative facts from... side effects protein kinase cutaneous egfr inhibitors https://www.mdpi.com/1422-0067/24/4/3894 Adverse Toxic Effects of Tyrosine Kinase Inhibitors on Non-Target Zebrafish Liver (ZFL) Cells Over the past 20 years, numerous tyrosine kinase inhibitors (TKIs) have been introduced for targeted therapy of various types of malignancies. Due to frequent... https://www.ebi.ac.uk/chembl/explore/document/CHEMBL2177102 Document: Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family.... Report card for Document Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family. (CHEMBL2177102). Bioorg Med Chem Lett,... https://pmc.ncbi.nlm.nih.gov/articles/PMC6993877/ Tyrosine Kinase Inhibitors (TKI) in Leukemia and Cardiovascular events - From mechanism to patient... Targeted oncology therapies have revolutionized cancer treatment over the last decade and have resulted in improved prognosis for many patients. This advance... tyrosine kinase inhibitors https://pmc.ncbi.nlm.nih.gov/articles/PMC6094551/ BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia - PMC The management of chronic myeloid leukemia with BCR-ABL1 tyrosine kinase inhibitors has evolved chronic myeloid leukemia into a chronic, manageable disease. A... tyrosine kinase inhibitors https://www.ebi.ac.uk/chembl/explore/document/CHEMBL5727412 Document: Substituted pyrazin-2-amines as inhibitors of ATR kinase (CHEMBL5727412) - ChEMBL Report card for Document Substituted pyrazin-2-amines as inhibitors of ATR kinase (CHEMBL5727412). . https://www.rcsb.org/structure/2WMU RCSB PDB - 2WMU: Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors Crystal structure of checkpoint kinase 1 (Chk1) in complex with inhibitors https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1138683/full Frontiers | Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic... Tyrosine kinase inhibitor(TKI) therapy has greatly improved the prognosis of patients with chronic myeloid leukemia(CML), improving the survival expectancy o... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1005626/full Frontiers | Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An... Non-small cell lung cancer (NSCLC) is often caused by molecular alterations that can be detected by predictive biomarkers including mutations or amplificatio... https://elifesciences.org/articles/12187 Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and... Chemical inhibition of Bub1 shows that the catalytic activity is not required for normal mitotic progression, but it makes chromosome segregation and cell... https://www.acc.org/Latest-in-Cardiology/Articles/2023/08/15/16/45/CV-Adverse-Effects-of-Novel-Bruton-Tyrosine-Kinase-Inhibitors Cardiovascular Adverse Effects of Novel Bruton Tyrosine Kinase Inhibitors: What All Cardiologists... tyrosine kinase inhibitors adverse effects https://www.rcsb.org/structure/3FDN RCSB PDB - 3FDN: Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis... Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity structure based drug design https://interrogacao.org/ Current concepts in The identification and characterisation of Rho Kinase Inhibitors - Just another... May 20, 2026 - Just another WordPress site https://www.muni.cz/en/research/publications/2481479 Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors |... https://www.osti.gov/pages/biblio/2423656-structure-btk-kinase-domain-second-generation-inhibitors-acalabrutinib-tirabrutinib Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib... The U.S. Department of Energy's Office of Scientific and Technical Information the second generation